- Home
- ADPT vs DRVN Comparison
ADPT vs DRVN Comparison
Compare ADPT & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- DRVN
- Stock Information
- Founded
- ADPT 2009
- DRVN 1972
- Country
- ADPT United States
- DRVN United States
- Employees
- ADPT N/A
- DRVN N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- DRVN Automotive Aftermarket
- Sector
- ADPT Health Care
- DRVN Consumer Discretionary
- Exchange
- ADPT Nasdaq
- DRVN Nasdaq
- Market Cap
- ADPT 2.6B
- DRVN 2.4B
- IPO Year
- ADPT 2019
- DRVN 2021
- Fundamental
- Price
- ADPT $20.36
- DRVN $14.36
- Analyst Decision
- ADPT Strong Buy
- DRVN Buy
- Analyst Count
- ADPT 10
- DRVN 7
- Target Price
- ADPT $16.60
- DRVN $20.43
- AVG Volume (30 Days)
- ADPT 2.4M
- DRVN 1.3M
- Earning Date
- ADPT 11-05-2025
- DRVN 11-04-2025
- Dividend Yield
- ADPT N/A
- DRVN N/A
- EPS Growth
- ADPT N/A
- DRVN N/A
- EPS
- ADPT N/A
- DRVN N/A
- Revenue
- ADPT $252,754,000.00
- DRVN $2,439,296,000.00
- Revenue This Year
- ADPT $36.43
- DRVN N/A
- Revenue Next Year
- ADPT $12.31
- DRVN $7.91
- P/E Ratio
- ADPT N/A
- DRVN N/A
- Revenue Growth
- ADPT 42.57
- DRVN 18.60
- 52 Week Low
- ADPT $4.76
- DRVN $13.44
- 52 Week High
- ADPT $20.76
- DRVN $19.74
- Technical
- Relative Strength Index (RSI)
- ADPT 73.37
- DRVN 48.25
- Support Level
- ADPT $13.28
- DRVN $13.44
- Resistance Level
- ADPT $14.24
- DRVN $14.43
- Average True Range (ATR)
- ADPT 1.19
- DRVN 0.48
- MACD
- ADPT 0.57
- DRVN 0.08
- Stochastic Oscillator
- ADPT 95.19
- DRVN 76.10
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.